Naxia Zhao

Title: Naxia Zhao: Innovator in Pharmaceutical Research

Introduction

Naxia Zhao is a distinguished inventor based in Tianjin, China, known for her contributions to the field of pharmaceutical research. With an impressive portfolio, she has a patent that addresses significant health concerns, particularly related to cardiovascular diseases.

Latest Patents

Naxia Zhao holds a notable patent titled "Cycloastragenol monoglucoside, preparation, pharmaceutical composition and application thereof." This invention presents a novel method for preparing cycloastragenol monoglucoside (CMG), which has potential therapeutic applications. The process involves using astragaloside IV or Astragali extracts as raw materials, followed by hydrolysis with hydrolase, separation using macroporous adsorption resin, and purification. This innovative approach allows for the creation of a medicament aimed at treating cardiovascular diseases.

Career Highlights

Naxia Zhao works at the Tianjin Institute of Pharmaceutical Research, a leading institution in the field of drug development and innovative pharmaceutical solutions. Her research focuses on creating effective substances that can enhance health outcomes for patients suffering from cardiovascular conditions.

Collaborations

Throughout her career, Naxia has collaborated with several talented individuals, including Yingmei Han and Guangping Xia. These partnerships have proven vital in advancing research initiatives and fostering innovation within the pharmaceutical industry.

Conclusion

Naxia Zhao exemplifies the spirit of innovation and dedication in the field of pharmaceutical research. Her patent on cycloastragenol monoglucoside not only showcases her inventiveness but also her commitment to improving health and addressing cardiovascular issues. With a strong background and collaborative spirit, Naxia continues to make impactful contributions to the industry.